Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. sophomore Avg
|
New words:
add, agency, ailing, Argentina, ASCO, assist, buyout, character, che, CHMP, Citizen, con, confirm, coordinated, CVP, cyclophoshamide, demonstrated, dialogue, discl, Distr, duly, eased, effort, EMEA, endothelial, EU, filling, frontline, fulfillment, Hoffmann, ict, illing, incr, infrastructure, introduced, investme, joint, La, licensure, MabThera, mantle, median, mmediately, modestly, multivariate, mutual, newly, nt, Nutrop, outlined, Oversight, peak, PFS, Pilot, posi, prednisone, recommending, Ro, run, sBLA, scheduled, select, Society, solidated, summer, Switzerland, targeted, tender, thousand, tion, unamortized, unclear, undertaken, unintended, vascular, VEGF, vel, vincristine, wer, wide
Removed:
accelerated, arbitration, auditing, breach, Certified, conversion, counterclaimed, directed, endpoint, enrichment, expressing, functional, fund, Germany, identified, immunoglobin, improving, independently, injunctive, misappropriation, payable, Penzberg, performed, Proxy, ruling, settlement, theft, unjust, worldwide
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 3.4 Restated Bylaws
- 3.5 Certificate of Third Amendment of Amended and Restated Certificate of Incorporation
- 10.18 Amendment, Dated March 10, 2000, to Amended and Restated Agreement Between Genentech and F. Hoffman-la Roche LTD Regarding Commercialization of Genentech's Products Outside the United States
- 10.19 Amendment, Dated June 26, 2000, to Amended and Restated Agreement Between Genentech and F. Hoffman-la Roche LTD Regarding Commercialization of Genentech's Products Outside the United States
- 10.20 Third Amendment, Dated April 30, 2004, to Amended and Restated Agreement Between Genentech and F. Hoffman-la Roche LTD Regarding Commercialization of Genentech's Products Outside the United States
- 10.21 Collaborative Agreement Among F. Hoffmann-la Roche LTD, Hoffmann-la Roche Inc. and Genentech, Dated April 13, 2004
- 15.1 Letter Regarding Unaudited Interim Financial Information
- 31.1 Certification of Chief Executive Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Promulgated Under the Securities Exchange Act of 1934, As Amended
- 31.2 Certification of Chief Financial Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Promulgated Under the Securities Exchange Act of 1934, As Amended
- 32.1 Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.s.c. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
Genentech similar filings
Filing view
External links